Antimicrobial resistance (AMR) is described as a 'silent pandemic.' Discuss how supply chain digitisation under Schedule H2 can contribute to India's AMR containment strategy.

AMR — pathogens surviving the drugs meant to kill them — spreads without visible outbreaks yet ranks among WHO's top ten global health threats [1]. Expanding Schedule H2 QR-code traceability to antimicrobials (notified June 2026) embeds supply-chain integrity into India's AMR fight [2].

AMR: the silent pandemic

• WHO flags AMR as driving untreatable infections and rising mortality, quietly eroding modern medicine [1].
• India is a hotspot — high antibiotic consumption, over-the-counter sale, and grey-market diversion accelerate resistance.

How Schedule H2 digitisation helps

• Unit-level QR/bar code on antimicrobials (effective 1 July 2028) enables end-to-end traceability: manufacturer → distributor → pharmacy → patient [2].
• Curbs spurious/sub-standard antibiotics — sub-therapeutic doses are a prime driver of resistance.
• Chokes grey-market and cross-border diversion; enables rapid batch recall and pharmacovigilance.
• Digital audit trail strengthens CDSCO and state drug-controller enforcement, complementing the surveillance pillar of NAP-AMR 2.0 (2025–29) [3].

Limits to note

• Traceability ≠ rational prescribing; overuse in humans, livestock and agriculture stays untouched.
• Digital divide — rural chemists and patient-end scanning remain weak.
• Needs a central QR repository and portal integration to be meaningful.

Supply-chain digitisation makes the antimicrobial chain visible and accountable — necessary but not sufficient. Paired with NAP-AMR 2.0's One Health surveillance and stewardship [3], Schedule H2 advances SDG-3 and a resistance-secure health system.